<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">OR</journal-id>
<journal-title-group>
<journal-title>Oncology Reports</journal-title></journal-title-group>
<issn pub-type="ppub">1021-335X</issn>
<issn pub-type="epub">1791-2431</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/or.2012.2016</article-id>
<article-id pub-id-type="publisher-id">or-28-05-1719</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject></subj-group></article-categories>
<title-group>
<article-title>Induction of apoptosis by 7-piperazinethylchrysin in HCT-116 human colon cancer cells</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>REN</surname><given-names>JIE</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>CHENG</surname><given-names>HONG</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>XIN</surname><given-names>WEN QUN</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>CHEN</surname><given-names>XIN</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>HU</surname><given-names>KUN</given-names></name><xref ref-type="corresp" rid="c1-or-28-05-1719"/></contrib>
<aff id="af1-or-28-05-1719">School of Pharmaceutical Engineering and Life Science, Changzhou University, Changzhou, Jiangsu 213164, P.R. China</aff></contrib-group>
<author-notes>
<corresp id="c1-or-28-05-1719"><italic>Correspondence to:</italic> Dr Kun Hu or Dr Xin Chen, School of Pharmaceutical Engineering and Life Science, Changzhou University, 1 Gehu Road, Changzhou, Jiangsu 213164, P.R. China, E-mail: <email>hukun1979@163.com</email>, E-mail: <email>xinchen@cczu.edu.cn</email></corresp></author-notes>
<pub-date pub-type="ppub">
<month>11</month>
<year>2012</year></pub-date>
<pub-date pub-type="epub">
<day>04</day>
<month>09</month>
<year>2012</year></pub-date>
<volume>28</volume>
<issue>5</issue>
<fpage>1719</fpage>
<lpage>1726</lpage>
<history>
<date date-type="received">
<day>09</day>
<month>07</month>
<year>2012</year></date>
<date date-type="accepted">
<day>13</day>
<month>08</month>
<year>2012</year></date></history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2012, Spandidos Publications</copyright-statement>
<copyright-year>2012</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0">
<license-p>This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.</license-p></license></permissions>
<abstract>
<p>The antitumor activity of 7-piperazinethylchrysin (7-PEC) was investigated in HCT-116 human colon cancer cells. MTT assay revealed that the IC<sub>50</sub> of 7-PEC in HCT-116 cells was 1.5 &#x003BC;M after 72 h of treatment, much lower than that of chrysin (&gt;100 &#x003BC;M). The data showed that 7-PEC was able to inhibit the growth of HCT-116 cells in a concentration- and time-dependent manner. Topical morphological changes of apoptotic body formation after 7-PEC treatment were observed by Hoechst 33258 staining. 7-PEC reduced mitochondrial membrane potential (<italic>&#x00394;&#x003A8;m</italic>) of cells in a concentration-dependent manner and increased the production of intracellular reactive oxygen species (ROS). After treatment with 7-PEC, a significant increase of Bax protein expression and decrease of Bcl-2 protein expression were observed at the same time. These events paralleled with activation of p53, caspase-3 and -9 and the release of cytochrome <italic>c</italic> (cyt-<italic>c</italic>), as well as poly(ADP-ribose) polymerase-1 (PARP1) cleavage and downregulation of p-Akt. However, the apoptosis induced by 7-PEC was blocked by Ac-DEVD-CHO, a caspase-3 inhibitor. These results demonstrate that 7-PEC-induced mitochondrial dysfunction in HCT-116 human colon cancer cells triggers events responsible for caspase-dependent apoptosis pathways, and the elevated ratio of Bax/Bcl-2 is likely involved in this effect.</p></abstract>
<kwd-group>
<kwd>7-piperazinethylchrysin</kwd>
<kwd>HCT-116</kwd>
<kwd>apoptosis</kwd>
<kwd>mitochondria</kwd>
<kwd>caspase-3</kwd>
<kwd>reactive oxygen species</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Apoptosis is an important continuous process of destruction of undesirable cells during development or homeostasis in multi-cellular organisms. This process is characterized by distinct morphological changes, including membrane bleeding, cell shrinkage, dissipation of mitochondrial membrane potential (<italic>&#x00394;&#x003A8;m</italic>), chromatin condensation and DNA fragmentation (<xref rid="b1-or-28-05-1719" ref-type="bibr">1</xref>,<xref rid="b2-or-28-05-1719" ref-type="bibr">2</xref>). The extrinsic and intrinsic pathways are the two major pathways involved in the regulation of apoptosis (<xref rid="b3-or-28-05-1719" ref-type="bibr">3</xref>): the extrinsic pathway is mediated via cell surface death receptor, leading to the activation of caspase-8; the intrinsic pathway is dependent on various cell stress stimuli, leading to altered ratio of Bcl-2 family members which affect cytochrome <italic>c</italic> (cyt-<italic>c</italic>), Smac and apoptotic protease activating factor-1 (Apaf-1) release that leads to caspase-9 and -3 activation (<xref rid="b4-or-28-05-1719" ref-type="bibr">4</xref>). Several therapeutic agents eliminate tumor cells by inducing apoptotic cell death (<xref rid="b5-or-28-05-1719" ref-type="bibr">5</xref>), and some natural plants have been investigated for their cytotoxicity in cancer targeting apoptosis (<xref rid="b6-or-28-05-1719" ref-type="bibr">6</xref>).</p>
<p>Flavonoids are a diverse family of natural phenolic compounds commonly found in fruits and vegetables, such as flavonols, flavonones and flavans. They have demonstrated anticancer and chemopreventive properties in numerous epidemiological studies (<xref rid="b7-or-28-05-1719" ref-type="bibr">7</xref>), and were able to inhibit the proliferation of tumor cells, such as breast, prostate and lung cancer cells, both <italic>in vitro</italic> and <italic>in vivo</italic> (<xref rid="b8-or-28-05-1719" ref-type="bibr">8</xref>,<xref rid="b9-or-28-05-1719" ref-type="bibr">9</xref>), although the exact mechanism is not yet fully understood. The flavonoids are generally safe with low toxicity, making them ideal candidates for cancer chemopreventive agents. Chrysin (5,7-dihydroxyflavone) is a natural flavonoid presented in many plant extracts, including blue passion flower (<italic>Passiflora caerulea</italic>), honey and propolis (<xref rid="b10-or-28-05-1719" ref-type="bibr">10</xref>). A number of studies have shown that chrysin has multiple biological activities, such as antiinflammation, antioxidation and anticancer effects (<xref rid="b11-or-28-05-1719" ref-type="bibr">11</xref>&#x02013;<xref rid="b13-or-28-05-1719" ref-type="bibr">13</xref>). Chrysin has been reported to induce apoptosis in a panel of cancer cell lines, including HeLa cervical cancer cells, U937, HL-60 and L1210 leukemia cells (<xref rid="b14-or-28-05-1719" ref-type="bibr">14</xref>). Chrysin was also able to inhibit tumor angiogenesis <italic>in vivo</italic>, which is a key step in cancer cell metastasis (<xref rid="b15-or-28-05-1719" ref-type="bibr">15</xref>,<xref rid="b16-or-28-05-1719" ref-type="bibr">16</xref>). We previously reported that 7-piperazinethylchrysin (7-PEC) (<xref rid="f1-or-28-05-1719" ref-type="fig">Fig. 1</xref>) significantly inhibited the growth of various cancer cell lines such as HCT-116 cells (<xref rid="b17-or-28-05-1719" ref-type="bibr">17</xref>). The aim of the present study was to elucidate the mechanisms of cell growth inhibition induced by 7-PEC. Herein we report that 7-PEC can inhibit the proliferation of HCT-116 cells in a time- and dose-dependent manner, including the <italic>&#x00394;&#x003A8;m</italic> loss, elevating the ratio of Bax/Bcl-2, releasing cyt-<italic>c</italic> to cell cytoplasm, activating caspase-9, -3 and p53, followed by PARP cleavage and induction of apoptosis.</p></sec>
<sec sec-type="methods">
<title>Materials and methods</title>
<sec>
<title>Materials</title>
<p>7-PEC was synthesized according to the procedure described in our previous report (<xref rid="b17-or-28-05-1719" ref-type="bibr">17</xref>). 7-PEC (&gt;95&#x00025; purity) was dissolved in DMSO and added to the experimental media to give the final concentrations. Antibodies for detecting p-Akt, Akt, p53, Bcl-2, Bax, cyt-<italic>c</italic>, pro-caspase-9, pro-caspase-3, PARP1 and &#x003B2;-actin were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). Ac-DEVD-CHO and Rhodamine 123 were purchased from the Beyotime Institute of Biotechnology (Haimen, China). Hoechst 33258 and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were purchased from Sigma-Aldrich (St. Louis, MO, USA). RPMI-1640 was purchased from Gibco (Invitrogen, Carlsbad, CA, USA). Neonatal bovine serum (NBS) was purchased from Hangzhou Sijiqing Biological Engineering Materials Co. (China).</p></sec>
<sec>
<title>Cell line and culture conditions</title>
<p>HCT-116 human colon cancer cells were kindly provided by Shanghai Jiao Tong University. The cells were routinely cultured in RPMI-1640 medium, supplemented with 10&#x00025; NBS. The culture was maintained at 37&#x000B0;C with a gas mixture of 5&#x00025; CO<sub>2</sub>/95&#x00025; air. All media were supplemented with 100 U/ml penicillin and 100 &#x003BC;g/ml streptomycin.</p></sec>
<sec>
<title>Cell viability assay</title>
<p>The cells were seeded in 96-well microtiter plates (3&#x000D7;10<sup>4</sup>/ml). After 12 h of incubation in the appropriate medium, cells were treated with various concentrations (1, 10, 25 and 50 &#x003BC;M ) of 7-PEC for another 72 h (24 or 48 h). Subsequently, 10 &#x003BC;l of MTT stock solution was added to each well for an additional 4 h of incubation. Then, 100 &#x003BC;l of DMSO was added to each well and the absorbance at 570 nm was determined with a microplate reader. Using the MTT method, cell numbers were obtained as absorbance values. The results were expressed as viability compared with that of control cells. Each treatment and time-point had three independent wells. The representative data shown in this study are the results of three independent experiments.</p></sec>
<sec>
<title>Cell morphological assessment</title>
<p>Cell morphological changes were assessed by Hoechst 33258 staining. Briefly, following exposure to 7- PEC for 48 h, the cells were washed twice with PBS and fixed with 4&#x00025; formaldehyde at 4&#x000B0;C for 10 min. The samples were then washed with PBS and stained with Hoechst 33258 solution (0.5 &#x003BC;g/ml) for 10 min at room temperature. Finally, the cells were observed under the fluorescence microscope (Nikon Eclipse Ti-s, Nikon Corp., Tokyo, Japan).</p></sec>
<sec>
<title>Detection of mitochondrial membrane potential</title>
<p><italic>&#x00394;&#x003A8;m</italic> was measured using Rhodamine 123. Briefly, cells under different concentrations of 7-PEC treatment were incubated with Rhodamine 123 (5 &#x003BC;g/ml) at 37&#x000B0;C for 30 min, and washed with PBS. The cell pellet was collected by centrifugation (1,500 &#x000D7; g, 3 min), and resuspended in 1 ml of PBS. Fluorescence intensities of Rhodamine 123 in cells were analyzed by flow cytometric analysis.</p></sec>
<sec>
<title>Cell cycle analysis</title>
<p>For cell cycle analysis, HCT-116 cells (1&#x000D7;10<sup>5</sup> cells/ml, 3 ml) were cultured in 6-well plates, with or without 7-PEC (1.25, 2.5 and 5 &#x003BC;M) for 48 h. Cells were collected and resuspended in 500 &#x003BC;l of PBS containing 0.025 mg of propidium iodide (PI) and 50 &#x003BC;g of RNase for 30 min at room temperature in the dark. Flow cytometry was performed on Quanta SC (Beckman Coulter, Fullerton, CA, USA).</p></sec>
<sec>
<title>Annexin V-FITC/PI assay of apoptotic cells</title>
<p>Briefly, HCT-116 cells (1&#x000D7;10<sup>5</sup> cells/ml) exposed to 7-PEC for 48 h were determined by flow cytometry (Quanta SC, Beckman Coulter) using a detection kit. Following 7-PEC treatment, cells were collected and washed twice in cold PBS and resuspended in 200 &#x003BC;l of binding buffer (1&#x000D7;10<sup>5</sup> cells/ml). The samples were incubated with 5 &#x003BC;l of Annexin V-FITC and 5 &#x003BC;l PI in the dark for 15 min at room temperature. Finally, samples were analyzed by flow cytometry and evaluated based on the percentage of cells for Annexin V-positive.</p></sec>
<sec>
<title>Western blot analysis</title>
<p>HCT-116 cells were treated with 7-PEC (1.25, 2.5 and 5 &#x003BC;M) for 48 h. Proteins were extracted with cell lysis buffer for western and IP (Beyotime Institute of Biotechnology). Equal amounts (40 &#x003BC;g/lane) of protein were separated on 10 or 15&#x00025; SDS-polyacrylamide gel electrophoresis, transferred to polyvinylidene fluoride (PVDF) membranes (Millipore Corp., Bedford, MA, USA) and blocked at room temperature for 1 h in 3&#x00025; (w/v) non-fat milk in TBST. The blots were incubated overnight at 4&#x000B0;C with the primary antibodies diluted in TBST buffer. The membranes were incubated with anti-Akt, p-Akt, Bcl-2, Bax, p53, cyt-<italic>c</italic>, pro-casapse-3, pro-caspase-9, PARP1 and &#x003B2;-actin primary antibodies (1:1000). After washing with TBST, the membranes were incubated with horseradish peroxidase-conjugated goat anti-rabbit or goat anti-mouse secondary antibodies (1:5000), and visualized with the ECL detection kit (Thermo, USA), according to the manufacturer&#x02019;s instructions.</p></sec>
<sec>
<title>Measurement of ROS production</title>
<p>The elevations of intracellular ROS induced by 7-PEC in HCT-116 cells were detected by DCFH-DA (2&#x02032;,7&#x02032;-dichlorofluorescein diacetate) using flow cytometry. This compound is a cell-permeant indicator for ROS that is non-fluorescent until the acetate groups are removed by intracellular esterases and oxidation occurs within the cell. Briefly, cells were seeded at 1&#x000D7;10<sup>5</sup> cells/well in 6-well plates, and treated with or without 7-PEC (5, 10 and 20 &#x003BC;M). At the indicated times, cells were harvested and washed with PBS, then resuspended in PBS containing DCFH-DA (10 &#x003BC;M) and incubated for 20 min at 37&#x000B0;C. After the inhibition, cells were washed twice by PBS and then analyzed by flow cytometry.</p></sec>
<sec>
<title>Statistical analysis</title>
<p>Results are expressed as the mean &#x000B1; SD for three independent experiments. Statistical differences were evaluated using Student&#x02019;s t-test or one-way analysis of variance (ANOVA). P&lt;0.05 was considered to indicate statistically significant differences.</p></sec></sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title>Effects of 7-PEC on cell viability</title>
<p>The cytotoxic effects of 7-PEC on five different cell lines were examined by MTT assay. The results showed that the cytotoxicity of 7-PEC on HCT-116 cells is most potent; it is comparable with that of 5-FU as a positive control (<xref rid="tI-or-28-05-1719" ref-type="table">Table I</xref>). HCT-116 cells in exponential growth were treated with graded concentrations of 7-PEC (1, 10, 25 and 50 &#x003BC;M) for 24, 48 and 72 h. Under the experimental conditions, 7-PEC treatment exhibited strong inhibition on the survival of HCT-116 cells in a time- and dose-dependent manner as shown in <xref rid="f2-or-28-05-1719" ref-type="fig">Fig. 2</xref>. The IC<sub>50</sub> values were calculated as 16.25, 5.49 and 1.5 &#x003BC;M in cells treated for 24, 48 and 72 h, respectively.</p></sec>
<sec>
<title>Effects of 7-PEC on the morphology of HCT-116 cells</title>
<p>In order to elucidate whether the loss of HCT-116 cell viability induced by 7-PEC was associated with apoptosis, the occurrence of apoptosis was identified with Hoechst 33258 staining. HCT-116 cells were incubated with various concentrations of 7-PEC (2.5 and 5 &#x003BC;M) for 48 h and stained by Hoechst 33258 for observation of the morphology. As is clearly shown in <xref rid="f3-or-28-05-1719" ref-type="fig">Fig. 3E</xref>, significant nuclear condensation and morphological changes for HCT-116 cells were observed, whereas in the control group, the cells without 7-PEC treatment demonstrated normal nuclear morphology. These data confirmed that 7-PEC could induce apoptosis in HCT-116 cells.</p></sec>
<sec>
<title>Effects of 7-PEC on cell cycle and apoptosis</title>
<p>To investigate the effects of 7-PEC on apoptosis and the cell cycle of HCT-116 cells, sub-diploid DNA-content and phosphatidylserine (PS) externalization were measured by FACS after PI and Annexin V-FITC/PI staining. For the cell cycle study, HCT-116 cells were treated with 7-PEC (1.25, 2.5 and 5 &#x003BC;M) for 48 h, and the DNA content of 10, 000 events was analyzed by flow cytometry. <xref rid="f3-or-28-05-1719" ref-type="fig">Fig. 3A and B</xref> show a dose-dependent increase of apoptosis induction which is indicated by percentage of sub-diploid DNA content. Apoptotic cells reached ~8.53 and 22.27&#x00025; when the cells were exposed to 2.5 and 5 &#x003BC;M of 7-PEC, respectively. For the apoptosis study, HCT-116 cells were incubated with different concentrations of 7-PEC (4, 6, 8 and 10 &#x003BC;M) for 48 h, and then the cells were subjected to Annexin V-FITC/PI staining and analyzed by flow cytometry. Significant apoptosis for HCT-116 cells is observed in <xref rid="f3-or-28-05-1719" ref-type="fig">Fig. 3C and D</xref>. Upon treatment with 2 and 10 &#x003BC;M of 7-PEC, the percentage of apoptotic cells increased from 3.09 to 50.03&#x00025;. These results suggest that the Annexin-V-FITC assay is more sensitive than sub-diploid DNA-content measurement for the evaluation of apoptosis.</p></sec>
<sec>
<title>Effects of 7-PEC on caspase-3 activity</title>
<p>Caspase, a family of cysteine proteases, is known to form integral parts of the apoptotic pathway (<xref rid="b18-or-28-05-1719" ref-type="bibr">18</xref>). Caspase-3 activation is considered the central and final apoptotic marker enzyme for both mitochondrial intrinsic and death-domain receptor-dependent extrinsic pathways. Poly(ADP-ribose) polymerase (PARP), an enzyme involved in DNA repair, is a substrate for caspase-3 (<xref rid="b19-or-28-05-1719" ref-type="bibr">19</xref>). Therefore, we investigated the protein levels and activity of caspase-3. As is shown in <xref rid="f4-or-28-05-1719" ref-type="fig">Fig. 4E</xref>, the pro-caspase-9 and -3 protein levels were significantly decreased and cleavage of PARP1 was detected in 7-PEC-treated HCT-116 cells.</p>
<p>To confirm whether 7-PEC specifically triggers caspase-3 expression, caspase-3 protein expression was investigated in HCT-116 cells by treating with 5 &#x003BC;M of 7-PEC for 48 h in the presence or absence of caspase-3 inhibitor, Ac-DEVD-CHO. As shown in <xref rid="f4-or-28-05-1719" ref-type="fig">Fig. 4C</xref>, activation of caspase-3 induced by 7-PEC is blocked in the presence of Ac-DEVD-CHO. MTT results demonstrated that the cell growth inhibition activity of 7-PEC was also weakened by Ac-DEVD-CHO (<xref rid="f4-or-28-05-1719" ref-type="fig">Fig. 4F</xref>). These data suggest that 7-PEC-induced apoptosis might engage caspase-3 dependent signaling cascades. Taken together, our results indicate that 7-PEC-induced apoptosis is possibly via the caspase-dependent apoptotic pathway in HCT-116 cells.</p></sec>
<sec>
<title>Effects of 7-PEC on p53/mitochondria-related apoptotic markers</title>
<p>The expression of Akt, p-Akt, p53, pro-caspase-3, pro-caspase-9, PARP1 and cyt-<italic>c</italic> was measured in HCT-116 cells treated with 7-PEC (1.25, 2.5 and 5 &#x003BC;M). As is shown in <xref rid="f4-or-28-05-1719" ref-type="fig">Fig. 4</xref>, 7-PEC treatment resulted in the decrease of antiapoptotic protein Bcl-2 and increase of the Bax (<xref rid="f4-or-28-05-1719" ref-type="fig">Fig. 4A</xref>), with an increase in the Bax/Bcl-2 ratio (<xref rid="f4-or-28-05-1719" ref-type="fig">Fig. 4B</xref>). In addition, upregulation of p53, cyt-<italic>c</italic>, pro-caspase-3, pro-caspase-9 and subsequent cleavage of PARP1 were detected in 7-PEC-treated HCT-116 cells. The exposure to 7-PEC had no effects on steady-state levels of total Akt protein, whereas p-Akt levels were decreased significantly in a dose-dependent manner (<xref rid="f4-or-28-05-1719" ref-type="fig">Fig. 4E</xref>). These findings suggest the activation of the mitochondria-based intrinsic apoptosis in HCT-116 cells after 7-PEC treatment.</p></sec>
<sec>
<title>Effects of 7-PEC on mitochondrial membrane potential</title>
<p>Early apoptosis is always accompanied by the disruption of the mitochondrial membrane, resulting in a rapid collapse in the electrochemical gradient (<xref rid="b20-or-28-05-1719" ref-type="bibr">20</xref>). In this study, we explored the effects of 7-PEC on the loss of <italic>&#x00394;&#x003A8;m</italic> using a cationic dye Rhodamine 123, which can diffuse into the mitochondria matrix and reflect the change of <italic>&#x00394;&#x003A8;m</italic> (<xref rid="b21-or-28-05-1719" ref-type="bibr">21</xref>). Thus, HCT-116 cells were incubated with different concentrations of 7-PEC (4, 6, 8 and 10 &#x003BC;M) for 24 h, and then incubated with Rhodamine 123 dye for another 30 min. Fluorescence emission was measured by flow cytometry. As shown in <xref rid="f5-or-28-05-1719" ref-type="fig">Fig. 5</xref>, the <italic>&#x00394;&#x003A8;m</italic> was significantly decreased by 7-PEC in a dose-dependent manner.</p></sec>
<sec>
<title>Effects of 7-PEC on cellular reactive oxygen species production</title>
<p>Increased production of reactive oxygen species (ROS) triggers cytotoxicity and cell death by increasing oxidative stress. The intracellular production of ROS in HCT-116 cells was measured while treating with 7-PEC (5, 10 and 20 &#x003BC;M) and using DCFH-DA staining. The 7-PEC treatment of HCT-116 cells induced a dose-dependent increase of ROS production. <xref rid="f6-or-28-05-1719" ref-type="fig">Fig. 6</xref> shows an example of FACS analysis of DCFH-DA-stained HCT-116 cells after 7-PEC treatment. The experiments were triplicated and similar results were obtained.</p></sec></sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>MTT assay revealed that 7-PEC significantly exerts growth inhibitory effects on various cell lines, particularly on HCT-116 human colon cancer cells with IC<sub>50</sub> at 1.5 &#x003BC;M after treating with 7-PEC for 72 h. We speculated that apoptosis may be the main mechanism for 7-PEC-induced growth inhibitory effects on HCT-116 cells. Previous studies have shown that a number of anticancer drugs induce apoptosis through the activation of the caspase pathways and the mitochondrial membrane dysfunction. Accumulating evidence indicates that mitochondria play a pivotal role in the apoptotic process in mammalian cells (<xref rid="b22-or-28-05-1719" ref-type="bibr">22</xref>&#x02013;<xref rid="b24-or-28-05-1719" ref-type="bibr">24</xref>). Disruption of mitochondrial <italic>&#x00394;&#x003A8;m</italic> is considered to be an indicator of mitochondria damage and is generally defined as an early stage of apoptosis, preceding efflux of small molecules from the mitochondria (including cytochrome <italic>c</italic>, apoptosis-inducing factor) and followed by caspase-9/-3 cascade activation (<xref rid="b25-or-28-05-1719" ref-type="bibr">25</xref>&#x02013;<xref rid="b28-or-28-05-1719" ref-type="bibr">28</xref>). In the present study, we found the marked decrease of pro-caspases (pro-caspase-3 and -9) by 7-PEC after the breakdown of <italic>&#x00394;&#x003A8;m</italic>, suggesting that the mitochondria-mediated pathway is involved in 7-PEC-triggered apoptosis. Sequential disruption of <italic>&#x00394;&#x003A8;m</italic>, increased Bax/Bcl-2 ratio and activation of caspases-9 and -3 was involved in 7-PEC-induced apoptosis. We showed that 7-PEC treatment activated caspase-3 in a dose-dependent manner and resulted in the cleavage of PARP1, a well-known caspase-3 substrate. A more significant accumulation of the p53 protein in HCT-116 cells was also observed after 7-PEC treatment, and this result indicates that the 7-PEC-induced apoptosis could be p53-dependent.</p>
<p>Akt, a serine/threonine protein kinase, is activated by phosphorylation and protects cells from apoptosis (<xref rid="b29-or-28-05-1719" ref-type="bibr">29</xref>), and this protection is the result of the fact that p-Akt increases expression of the FLICE inhibitory protein (FLIP), which inhibits caspase-8 activity (<xref rid="b30-or-28-05-1719" ref-type="bibr">30</xref>). We found that 7-PEC induced downregulation/dephosphorylation of p-Akt.</p>
<p>The overexpression and integration of Bax in the mitochondrial membrane were responsible for the commitment of the cells to apoptosis (<xref rid="b31-or-28-05-1719" ref-type="bibr">31</xref>). Bcl-2 is localized in the mitochondria, endoplasmic reticulum, and nuclear membranes, where most of the oxygen-free radicals are generated and where the free radicals exert their apoptotic effects. Bcl-2 possibly acts to prevent apoptosis by scavenging oxygen derived free radicals inside the cells (<xref rid="b32-or-28-05-1719" ref-type="bibr">32</xref>,<xref rid="b33-or-28-05-1719" ref-type="bibr">33</xref>). The increase of the Bax/Bcl-2 ratio could induce cell apoptosis (<xref rid="b34-or-28-05-1719" ref-type="bibr">34</xref>,<xref rid="b35-or-28-05-1719" ref-type="bibr">35</xref>). Treatment of HCT-116 cells with 7-PEC decreased the Bcl-2 and increased the Bax protein levels. We speculate that ROS might modulate the cellular distribution and content of Bcl-2. Generation of ROS may contribute to mitochondrial damage and lead to cell death by acting as apoptotic signaling molecules (<xref rid="b36-or-28-05-1719" ref-type="bibr">36</xref>&#x02013;<xref rid="b39-or-28-05-1719" ref-type="bibr">39</xref>). In the present study, we found that in addition to its effect on <italic>&#x00394;&#x003A8;m</italic>, 7-PEC caused an increase in ROS production in HCT-116 cells. The 7-PEC-mediated disruption of <italic>&#x00394;&#x003A8;m</italic> and apoptosis in HCT-116 cells are apparently dependent on ROS generation.</p>
<p>In conclusion, the present study demonstrates that the significant growth inhibitory effects of 7-PEC on HCT-116 human colon cancer cells is associated with induction of apoptosis, involving sequential events, such as ROS production, reducing the mitochondrial membrane potential (<italic>&#x00394;&#x003A8;m</italic>), and increasing the Bax/Bcl-2 protein ratio.</p></sec></body>
<back>
<ack>
<title>Acknowledgements</title>
<p>This study was financially supported by the 2010 Industry for Attracting PhD Scientists Program of Jiangsu Province, Changzhou Key Technology R&amp;D Program (social development) and the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions.</p></ack>
<ref-list>
<title>References</title>
<ref id="b1-or-28-05-1719"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufmann</surname><given-names>SH</given-names></name><name><surname>Hengartner</surname><given-names>MO</given-names></name></person-group><article-title>Programmed cell death: alive and well in the new millennium</article-title><source>Trends Cell Biol</source><volume>11</volume><fpage>526</fpage><lpage>534</lpage><year>2001</year></element-citation></ref>
<ref id="b2-or-28-05-1719"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reed</surname><given-names>JC</given-names></name></person-group><article-title>Apoptosis-regulating proteins as targets for drug discovery</article-title><source>Trends Mol Med</source><volume>7</volume><fpage>314</fpage><lpage>319</lpage><year>2001</year></element-citation></ref>
<ref id="b3-or-28-05-1719"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Earnshaw</surname><given-names>WC</given-names></name><name><surname>Martins</surname><given-names>LM</given-names></name><name><surname>Kaufmann</surname><given-names>SH</given-names></name></person-group><article-title>Mammalian caspases: structure, activation, substrates, and functions during apoptosis</article-title><source>Annu Rev Biochem</source><volume>68</volume><fpage>383</fpage><lpage>424</lpage><year>1999</year></element-citation></ref>
<ref id="b4-or-28-05-1719"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>XM</given-names></name><name><surname>MacFarlane</surname><given-names>M</given-names></name><name><surname>Zhuang</surname><given-names>J</given-names></name><name><surname>Wolf</surname><given-names>BB</given-names></name><name><surname>Green</surname><given-names>DR</given-names></name><name><surname>Cohen</surname><given-names>GM</given-names></name></person-group><article-title>Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis</article-title><source>J Biol Chem</source><volume>274</volume><fpage>5053</fpage><lpage>5060</lpage><year>1999</year></element-citation></ref>
<ref id="b5-or-28-05-1719"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>CB</given-names></name></person-group><article-title>Apoptosis in the pathogenesis and treatment of disease</article-title><source>Science</source><volume>267</volume><fpage>1456</fpage><lpage>1462</lpage><year>1995</year></element-citation></ref>
<ref id="b6-or-28-05-1719"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>KH</given-names></name></person-group><article-title>Anticancer drug design based on plant-derived natural products</article-title><source>J Biomed Sci</source><volume>6</volume><fpage>236</fpage><lpage>250</lpage><year>1999</year></element-citation></ref>
<ref id="b7-or-28-05-1719"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arts</surname><given-names>IC</given-names></name></person-group><article-title>A review of the epidemiological evidence on tea, flavonoids, and lung cancer</article-title><source>J Nutr</source><volume>138</volume><fpage>S1561</fpage><lpage>S1566</lpage><year>2008</year></element-citation></ref>
<ref id="b8-or-28-05-1719"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kupeli</surname><given-names>E</given-names></name><name><surname>Sahin</surname><given-names>FP</given-names></name><name><surname>Yesilada</surname><given-names>E</given-names></name><name><surname>Calis</surname><given-names>I</given-names></name><name><surname>Ezer</surname><given-names>N</given-names></name></person-group><article-title>In vivo anti-inflammatory and antinociceptive activity evaluation of phenolic compounds from Sideritis stricta</article-title><source>J Biosci</source><volume>62</volume><fpage>519</fpage><lpage>525</lpage><year>2007</year></element-citation></ref>
<ref id="b9-or-28-05-1719"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terao</surname><given-names>J</given-names></name></person-group><article-title>Dietary flavonoids as antioxidants</article-title><source>Forum Nutr</source><volume>61</volume><fpage>87</fpage><lpage>94</lpage><year>2009</year></element-citation></ref>
<ref id="b10-or-28-05-1719"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sobocanec</surname><given-names>S</given-names></name><name><surname>Sverko</surname><given-names>V</given-names></name><name><surname>Balog</surname><given-names>T</given-names></name><etal/></person-group><article-title>Oxidant/antioxidant properties of Croatian native propolis</article-title><source>J Agric Food Chem</source><volume>54</volume><fpage>8018</fpage><lpage>8026</lpage><year>2006</year></element-citation></ref>
<ref id="b11-or-28-05-1719"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhawan</surname><given-names>K</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Sharma</surname><given-names>A</given-names></name></person-group><article-title>Beneficial effects of chrysin and benzoflavone on virility in 2-year-old male rats</article-title><source>J Med Food</source><volume>5</volume><fpage>43</fpage><lpage>48</lpage><year>2002</year></element-citation></ref>
<ref id="b12-or-28-05-1719"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lapidot</surname><given-names>T</given-names></name><name><surname>Walker</surname><given-names>MD</given-names></name><name><surname>Kanner</surname><given-names>J</given-names></name></person-group><article-title>Antioxidant and prooxidant effects of phenolics on pancreatic beta-cells in vitro</article-title><source>J Agric Food Chem</source><volume>50</volume><fpage>7220</fpage><lpage>7225</lpage><year>2002</year></element-citation></ref>
<ref id="b13-or-28-05-1719"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schnitzler</surname><given-names>P</given-names></name><name><surname>Neuner</surname><given-names>A</given-names></name><name><surname>Nolkem per</surname><given-names>S</given-names></name><name><surname>Zundel</surname><given-names>C</given-names></name><name><surname>Nowack</surname><given-names>H</given-names></name><name><surname>Sensch</surname><given-names>KH</given-names></name><name><surname>Reichling</surname><given-names>J</given-names></name></person-group><article-title>Antiviral activity and mode of action of propolis extracts and selected compounds</article-title><source>Phytother Res</source><volume>24</volume><fpage>S20</fpage><lpage>S28</lpage><year>2010</year></element-citation></ref>
<ref id="b14-or-28-05-1719"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khoo</surname><given-names>BY</given-names></name><name><surname>Chua</surname><given-names>SL</given-names></name><name><surname>Balaram</surname><given-names>P</given-names></name></person-group><article-title>Apoptotic effects of chrysin in human cancer cell lines</article-title><source>Int J Mol Sci</source><volume>11</volume><fpage>2188</fpage><lpage>2199</lpage><year>2010</year></element-citation></ref>
<ref id="b15-or-28-05-1719"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weng</surname><given-names>MS</given-names></name><name><surname>Ho</surname><given-names>YS</given-names></name><name><surname>Lin</surname><given-names>JK</given-names></name></person-group><article-title>Chrysin induces G1 phase cell cycle arrest in C6 glioma cells through inducing p21<sup>Waf1/Cip1</sup> expression: involvement of p38 mitogen-activated protein kinase</article-title><source>Biochem Pharmacol</source><volume>69</volume><fpage>1815</fpage><lpage>1827</lpage><year>2005</year></element-citation></ref>
<ref id="b16-or-28-05-1719"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>Q</given-names></name><name><surname>Ong</surname><given-names>CN</given-names></name><name><surname>Yang</surname><given-names>XF</given-names></name><name><surname>Shen</surname><given-names>HM</given-names></name></person-group><article-title>Chrysin sensitizes tumor necrosis factor-alpha-induced apoptosis in human tumor cells via suppression of nuclear factor-kappaB</article-title><source>Cancer Lett</source><volume>293</volume><fpage>109</fpage><lpage>116</lpage><year>2010</year></element-citation></ref>
<ref id="b17-or-28-05-1719"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Cheng</surname><given-names>H</given-names></name><name><surname>Pan</surname><given-names>SS</given-names></name><name><surname>Ren</surname><given-names>J</given-names></name></person-group><article-title>Synthesis and cytotoxicity of novel chrysin derivatives</article-title><source>Med Chem Res</source><volume>20</volume><fpage>838</fpage><lpage>846</lpage><year>2011</year></element-citation></ref>
<ref id="b18-or-28-05-1719"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thornberry</surname><given-names>NA</given-names></name><name><surname>Lazebnik</surname><given-names>Y</given-names></name></person-group><article-title>Caspase: enemies within</article-title><source>Science</source><volume>281</volume><fpage>1308</fpage><lpage>1312</lpage><year>1998</year></element-citation></ref>
<ref id="b19-or-28-05-1719"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>BH</given-names></name><name><surname>Kim</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>QC</given-names></name><etal/></person-group><article-title>Kinetin riboside preferentially induces apoptosis by modulating Bcl-2 family proteins and caspase-3 in cancer cells</article-title><source>Cancer Lett</source><volume>261</volume><fpage>37</fpage><lpage>45</lpage><year>2008</year></element-citation></ref>
<ref id="b20-or-28-05-1719"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ly</surname><given-names>JD</given-names></name><name><surname>Grubb</surname><given-names>DR</given-names></name><name><surname>Lawen</surname><given-names>A</given-names></name></person-group><article-title>The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update</article-title><source>Apoptosis</source><volume>8</volume><fpage>115</fpage><lpage>128</lpage><year>2003</year></element-citation></ref>
<ref id="b21-or-28-05-1719"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>PH</given-names></name><name><surname>Liu</surname><given-names>SQ</given-names></name><name><surname>Peng</surname><given-names>H</given-names></name></person-group><article-title>The effect of hyaluronic acid on IL-1beta-induced chondrocyte apoptosis in a rat model of osteoarthritis</article-title><source>J Orthop Res</source><volume>26</volume><fpage>1643</fpage><lpage>1648</lpage><year>2008</year></element-citation></ref>
<ref id="b22-or-28-05-1719"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ling</surname><given-names>YH</given-names></name><name><surname>Liebes</surname><given-names>L</given-names></name><name><surname>Zou</surname><given-names>Y</given-names></name><name><surname>Perez-Soler</surname><given-names>R</given-names></name></person-group><article-title>Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells</article-title><source>Biol Chem</source><volume>278</volume><fpage>33714</fpage><lpage>33723</lpage><year>2003</year></element-citation></ref>
<ref id="b23-or-28-05-1719"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryan</surname><given-names>L</given-names></name><name><surname>O&#x02019;Callaghan</surname><given-names>YC</given-names></name><name><surname>O&#x02019;Brien</surname><given-names>NM</given-names></name></person-group><article-title>The role of the mitochondria in apoptosis induced by 7&#x003B2;-hydroxycholesterol and cholesterol-5&#x003B2;, 6&#x003B2;-epoxide</article-title><source>Br J Nutr</source><volume>94</volume><fpage>519</fpage><lpage>525</lpage><year>2005</year></element-citation></ref>
<ref id="b24-or-28-05-1719"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group><article-title>Mitochondria are the primary target in isothiocyanate-induced apoptosis in human bladder cancer cells</article-title><source>Mol Cancer Ther</source><volume>4</volume><fpage>1250</fpage><lpage>1259</lpage><year>2005</year></element-citation></ref>
<ref id="b25-or-28-05-1719"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doi</surname><given-names>S</given-names></name><name><surname>Soda</surname><given-names>H</given-names></name><name><surname>Oka</surname><given-names>M</given-names></name><etal/></person-group><article-title>The histone deacetylase inhibitor FR901228 induces caspase-dependent apoptosis via the mitochondrial pathway in small cell lung cancer cells</article-title><source>Mol Cancer Ther</source><volume>3</volume><fpage>1397</fpage><lpage>1402</lpage><year>2003</year></element-citation></ref>
<ref id="b26-or-28-05-1719"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogbourne</surname><given-names>SM</given-names></name><name><surname>Suhrbier</surname><given-names>A</given-names></name><name><surname>Jones</surname><given-names>B</given-names></name><etal/></person-group><article-title>Antitumor activity of 3-ingenylangelate: plasma membrane and mitochondrial disruption and necrotic cell death</article-title><source>Cancer Res</source><volume>64</volume><fpage>2833</fpage><lpage>2839</lpage><year>2004</year></element-citation></ref>
<ref id="b27-or-28-05-1719"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rotem</surname><given-names>R</given-names></name><name><surname>Heyfets</surname><given-names>A</given-names></name><name><surname>Fingrut</surname><given-names>O</given-names></name><name><surname>Blickstein</surname><given-names>D</given-names></name><name><surname>Shaklai</surname><given-names>M</given-names></name><name><surname>Flescher</surname><given-names>E</given-names></name></person-group><article-title>Jasmonates: novel anticancer agents acting directly and selectively on human cancer cell mitochondria</article-title><source>Cancer Res</source><volume>65</volume><fpage>1984</fpage><lpage>1993</lpage><year>2005</year></element-citation></ref>
<ref id="b28-or-28-05-1719"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>CC</given-names></name><name><surname>Chan</surname><given-names>ML</given-names></name><name><surname>Chen</surname><given-names>WY</given-names></name><name><surname>Tsai</surname><given-names>CY</given-names></name><name><surname>Chang</surname><given-names>FR</given-names></name><name><surname>Wu</surname><given-names>YC</given-names></name></person-group><article-title>Pristimerin induces caspase-dependent apoptosis in MDA-MB-231 cells via direct effects on mitochondria</article-title><source>Mol Cancer Ther</source><volume>4</volume><fpage>1277</fpage><lpage>1285</lpage><year>2005</year></element-citation></ref>
<ref id="b29-or-28-05-1719"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franke</surname><given-names>TF</given-names></name><name><surname>Hornik</surname><given-names>CP</given-names></name><name><surname>Segev</surname><given-names>L</given-names></name><name><surname>Shostak</surname><given-names>GA</given-names></name><name><surname>Sugimoto</surname><given-names>C</given-names></name></person-group><article-title>PI3K/Akt and apoptosis: size matters</article-title><source>Oncogene</source><volume>22</volume><fpage>8983</fpage><lpage>8998</lpage><year>2003</year></element-citation></ref>
<ref id="b30-or-28-05-1719"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panka</surname><given-names>DJ</given-names></name><name><surname>Mano</surname><given-names>T</given-names></name><name><surname>Suhara</surname><given-names>T</given-names></name><name><surname>Walsh</surname><given-names>K</given-names></name><name><surname>Mier</surname><given-names>JW</given-names></name></person-group><article-title>Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells</article-title><source>J Biol Chem</source><volume>276</volume><fpage>6893</fpage><lpage>6896</lpage><year>2001</year></element-citation></ref>
<ref id="b31-or-28-05-1719"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayward</surname><given-names>RL</given-names></name><name><surname>Macpherson</surname><given-names>JS</given-names></name><name><surname>Cummings</surname><given-names>J</given-names></name><name><surname>Monia</surname><given-names>BP</given-names></name><name><surname>Smyth</surname><given-names>JF</given-names></name><name><surname>Jodrell</surname><given-names>DI</given-names></name></person-group><article-title>Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl down-regulation is p53 and Bax dependent: genetic evidence for specificity of the antisense effect</article-title><source>Mol Cancer Ther</source><volume>3</volume><fpage>169</fpage><lpage>178</lpage><year>2004</year></element-citation></ref>
<ref id="b32-or-28-05-1719"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinicrope</surname><given-names>FA</given-names></name><name><surname>Penington</surname><given-names>RC</given-names></name></person-group><article-title>Sulindac sulfide-induced apoptosis is enhanced by a small-molecule Bcl-2 inhibitor and by TRAIL in human colon cancer cells over-expressing Bcl-2</article-title><source>Mol Cancer Ther</source><volume>4</volume><fpage>1475</fpage><lpage>1483</lpage><year>2005</year></element-citation></ref>
<ref id="b33-or-28-05-1719"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamanaka</surname><given-names>K</given-names></name><name><surname>Rocchi</surname><given-names>P</given-names></name><name><surname>Miyake</surname><given-names>H</given-names></name><name><surname>Fazli</surname><given-names>L</given-names></name><name><surname>Vessella</surname><given-names>B</given-names></name><name><surname>Zangemeister-Wittke</surname><given-names>U</given-names></name><name><surname>Gleave</surname><given-names>ME</given-names></name></person-group><article-title>A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells</article-title><source>Mol Cancer Ther</source><volume>4</volume><fpage>1689</fpage><lpage>1698</lpage><year>2005</year></element-citation></ref>
<ref id="b34-or-28-05-1719"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Childs</surname><given-names>AC</given-names></name><name><surname>Phaneuf</surname><given-names>SL</given-names></name><name><surname>Dirks</surname><given-names>AJ</given-names></name><name><surname>Phillips</surname><given-names>T</given-names></name><name><surname>Leeuwenburgh</surname><given-names>C</given-names></name></person-group><article-title>Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2/Bax ratio</article-title><source>Cancer Res</source><volume>62</volume><fpage>4592</fpage><lpage>4598</lpage><year>2002</year></element-citation></ref>
<ref id="b35-or-28-05-1719"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katiyar</surname><given-names>SK</given-names></name><name><surname>Roy</surname><given-names>AM</given-names></name><name><surname>Baliga</surname><given-names>MS</given-names></name></person-group><article-title>Silymarin induces apoptosis primarily through a p53-dependent pathway involving Bcl-2/Bax, cytochrome c release, and caspase activation</article-title><source>Mol Cancer Ther</source><volume>4</volume><fpage>207</fpage><lpage>216</lpage><year>2005</year></element-citation></ref>
<ref id="b36-or-28-05-1719"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batra</surname><given-names>S</given-names></name><name><surname>Reynolds</surname><given-names>CP</given-names></name><name><surname>Maurer</surname><given-names>BJ</given-names></name></person-group><article-title>Fenretinide cytotoxicity for Ewing&#x02019;s sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators</article-title><source>Cancer Res</source><volume>64</volume><fpage>5415</fpage><lpage>5424</lpage><year>2004</year></element-citation></ref>
<ref id="b37-or-28-05-1719"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>CC</given-names></name><name><surname>Liu</surname><given-names>TY</given-names></name><name><surname>Cheng</surname><given-names>CH</given-names></name><name><surname>Jan</surname><given-names>TR</given-names></name></person-group><article-title>Involvement of the mitochondrion-dependent pathway and oxidative stress in the apoptosis of murine splenocytes induced by areca nut extract</article-title><source>Toxicol In Vitro</source><volume>23</volume><fpage>840</fpage><lpage>847</lpage><year>2009</year></element-citation></ref>
<ref id="b38-or-28-05-1719"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>D</given-names></name><name><surname>Powolny</surname><given-names>AA</given-names></name><name><surname>Antosiewicz</surname><given-names>J</given-names></name><etal/></person-group><article-title>Cellular responses to cancer chemopreventive agent D,L-sulforaphane in human prostate cancer cells are initiated by mitochondrial reactive oxygen species</article-title><source>Pharm Res</source><volume>26</volume><fpage>1729</fpage><lpage>1738</lpage><year>2009</year></element-citation></ref>
<ref id="b39-or-28-05-1719"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Kong</surname><given-names>X</given-names></name><name><surname>Kang</surname><given-names>J</given-names></name><name><surname>Su</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Zhong</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name></person-group><article-title>Oxidative stress induces parallel autophagy and mitochondria dysfunction in human glioma U251 cells</article-title><source>Toxicol Sci</source><volume>110</volume><fpage>376</fpage><lpage>388</lpage><year>2009</year></element-citation></ref></ref-list></back>
<floats-group>
<fig id="f1-or-28-05-1719" position="float">
<label>Figure 1</label>
<caption>
<p>Chemical structure of 7-PEC.</p></caption>
<graphic xlink:href="OR-28-05-1719-g00.gif"/></fig>
<fig id="f2-or-28-05-1719" position="float">
<label>Figure 2</label>
<caption>
<p>Effects of 7-PEC on cell viability. MTT assay was used to detect HCT-116 cells viability after treatment of different concentrations of 7-PEC for 24 h, 48 h and 72 h, respectively. The data shown are the mean from three parallel experiments. <sup>&#x0002A;</sup>p&lt;0.05, <sup>&#x0002A;&#x0002A;</sup>p&lt;0.01 compared to control.</p></caption>
<graphic xlink:href="OR-28-05-1719-g01.gif"/></fig>
<fig id="f3-or-28-05-1719" position="float">
<label>Figure 3</label>
<caption>
<p>Effects of 7-PEC on cell cycle and apoptosis of HCT-116 cells. (A) Effects of 7-PEC on the cell cycle of HCT-116 cells. Cells were treated with 7-PEC (1.25, 2.5 and 5 &#x003BC;M) for 48 h, and the DNA content of 10,000 events was analyzed by flow cytometry. (B) The proportions (&#x00025;) in each phase of the HCT-116 cells. <sup>&#x0002A;</sup>p&lt;0.05, <sup>&#x0002A;&#x0002A;</sup>p&lt;0.01 compared to control. (C) Effect of 7-PEC on cell apoptosis of HCT-116 cells. Induction of apoptosis was measured by Annexin-V/PI double-staining assay after treatment with 7-PEC (4, 6, 8 and 10 &#x003BC;M) for 48 h by flow cytometry. (D) The apoptotic proportion of HCT-116 cells treated with 7-PEC. <sup>&#x0002A;</sup>p&lt;0.05, <sup>&#x0002A;&#x0002A;</sup>p&lt;0.01 compared to control. (E) Effect of 7-PEC on the morphological changes of HCT-116 cells. HCT-116 cells were incubated with various concentrations of 7-PEC for 48 h and stained by Hoechst 33258 to observe the morphology.</p></caption>
<graphic xlink:href="OR-28-05-1719-g02.gif"/></fig>
<fig id="f4-or-28-05-1719" position="float">
<label>Figure 4</label>
<caption>
<p>Effects of 7-PEC on apoptosis-related proteins of HCT-116 cells. (A) Bcl-2 and Bax protein expressions. HCT-116 cells were treated with 7-PEC (1.25 and 2.5 &#x003BC;M) for 48 h. Western blot analysis was performed. (B) Ratio of Bax/Bcl-2 protein expressions using densitometric analysis. (C) Effect of 7-PEC on the activity of pro-caspase-3 in HCT-116 cells. HCT-116 cells were incubated with 5 &#x003BC;M 7-PEC in the presence or absence of 10 &#x003BC;M Ac-DEVD-CHO for 48 h. (D) Ratio of caspase-3/&#x003B2;-actin protein expressions. (E) Expression of apoptosis-related proteins in HCT-116 cells treated with 7-PEC. The levels of proteins including Akt, P-Akt, p53, cyt-<italic>c</italic>, pro-caspase-9, pro-caspase-3, PARP1 and &#x003B2;-actin in HCT-116 cells were assessed by western blot assay. RI values indicate relative intensity (of upper band) using expression of proteins in control untreated cells as 1. (F) Effect of capase-3 inhibitor on 7-PEC induced cell proliferation inhibition. MTT assay was carried out while HCT-116 cells in exponential growth were treated with graded concentrations (2, 4 and 6 &#x003BC;M) of 7-PEC in the presence or absence of 10 &#x003BC;M Ac-DEVD-CHO for 24 or 72 h.</p></caption>
<graphic xlink:href="OR-28-05-1719-g03.gif"/></fig>
<fig id="f5-or-28-05-1719" position="float">
<label>Figure 5</label>
<caption>
<p>Effect of 7-PEC on the mitochondrial membrane potential (<italic>&#x00394;&#x003A8;m)</italic> of HCT-116 cells. (A) Cells treated with 7-PEC for 24 h were incubated with Rhodamine 123 and measured by flow cytometry. The percentages of cells in the right section of the fluorocytogram indicate the number of <italic>&#x00394;&#x003A8;m</italic> collapsed cells. (B) Percentage loss of <italic>&#x00394;&#x003A8;m</italic> in the control and 7-PEC-treated cells.</p></caption>
<graphic xlink:href="OR-28-05-1719-g04.gif"/></fig>
<fig id="f6-or-28-05-1719" position="float">
<label>Figure 6</label>
<caption>
<p>Effect of 7-PEC on intracellular ROS of HCT-116 cells. Cells treated with 7-PEC for 24 h were incubated with DCFH-DA and measured by flow cytometry.</p></caption>
<graphic xlink:href="OR-28-05-1719-g05.gif"/></fig>
<table-wrap id="tI-or-28-05-1719" position="float">
<label>Table I</label>
<caption>
<p>The cytotoxicity of compound 7-PEC against the DU-145, SGC-7901, HCT-116, HeLa and HEK-293 cell lines.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom"/>
<th colspan="5" align="center" valign="bottom">Cytotoxicity (IC<sub>50</sub>, &#x003BC;M)<xref rid="tfn1-or-28-05-1719" ref-type="table-fn">a</xref></th></tr>
<tr>
<th align="left" valign="bottom"/>
<th colspan="5" align="left" valign="bottom">
<hr/></th></tr>
<tr>
<th align="left" valign="bottom">Compound</th>
<th align="center" valign="bottom">DU-145</th>
<th align="center" valign="bottom">SGC-7901</th>
<th align="center" valign="bottom">HCT-116</th>
<th align="center" valign="bottom">HeLa</th>
<th align="center" valign="bottom">HEK-293</th></tr></thead>
<tbody>
<tr>
<td align="left" valign="top">7-PEC</td>
<td align="center" valign="top">3.08</td>
<td align="center" valign="top">2.78</td>
<td align="center" valign="top">1.50</td>
<td align="center" valign="top">2.46</td>
<td align="center" valign="top">41.90</td></tr>
<tr>
<td align="left" valign="top">5-FU</td>
<td align="center" valign="top">2.95</td>
<td align="center" valign="top">2.19</td>
<td align="center" valign="top">1.93</td>
<td align="center" valign="top">9.70</td>
<td align="center" valign="top">&gt;100</td></tr></tbody></table>
<table-wrap-foot><fn id="tfn1-or-28-05-1719">
<label>a</label>
<p>Data are the mean of three independent experiments.</p></fn></table-wrap-foot></table-wrap></floats-group></article>
